Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

Posts Tagged ‘NASDAQ:AEZS’

biotech research company, bio-technology companies

Expectations Run High At AEterna Zentaris Inc. (USA) (AEZS) As Two New Drugs Enter Final Testing Phases

By Pablo Erbar In a recent interview with Small Cap Nation, CEO David Dodd, of AEterna Zentaris Inc. (USA) (NASDAQ:AEZS), and analyst Jeffrey Kraws, of......(read more)
people, person, lab, nuclear, hydrogen, concept, chemistry, technicians, researching, formula, chemists, biotechnology, researchers, discovery, weapon, samples,

AEterna Zentaris Inc. (USA) (AEZS) Is Down, But Probably Not Out

AEterna Zentaris Inc. (USA) (NASDAQ:AEZS) is taking a major hit premarket, having put out data from its lead trial after hours on Wednesday. The data......(read more)
dna, bio, clone, helix, medical, health, research, cell, gene, microscopic, render, tech, chemistry, molecular, liquid, life, biotechnology, technology, medicine, molecule,

AEterna Zentaris Inc. (USA) (AEZS) Lines Up A Binary Event Reversal For The First Quarter

AEterna Zentaris Inc. (USA) (NASDAQ:AEZS) just put out its third quarter 2016 earnings, and the company took a bit of a dive on the numbers. However,......(read more)
biotech, shares, market, amgen, percent, technical, economy, pharmaceutical, rate, quote, producer, drag, business, bio, capitalization, tech, biotechnology, sector, gain,,

Here Are Three Big Biotech Movers And Our Take On What’s Next

So we’re going to close out the week with a roundup of some of the companies that have moved the most over the last couple of sessions, and what’s......(read more)
Netflix, Inc. (NASDAQ:NFLX), homepage, streaming, Ipad, video, tv, tablet, app, watch,

Why Are These Stocks Seeing Green Today?

At a time when the major indexes are in bull market territory, shares of Electronic Arts Inc. (NASDAQ:EA), Alibaba Group Holding Ltd (NYSE:BABA), Netflix......(read more)
Most Consumed Products in the World

What’s the Deal With These 4 Plunging Stocks?

In what seems to be another swoon downwards for the S&P in afternoon trading, shares of AEterna Zentaris Inc. (USA) (NASDAQ:AEZS), Oncothyreon Inc......(read more)
Best States for Doctors to Practice Medicine

Do Hedge Funds Love AEterna Zentaris Inc. (USA) (AEZS)?

As we already know from media reports and hedge fund investor letters, many hedge funds lost money in the third quarter, blaming macroeconomic conditions......(read more)
pharmacist, medical, retail, worker, team, young, staff, lab, chemistry, business, drug, chemist, adult, teamwork, drugstore, service,

AEterna Zentaris Inc. (USA) (AEZS) Making Another Monster Move Today

After more than doubling yesterday, shares of AEterna Zentaris Inc. (USA) (NASDAQ:AEZS) are having another big day in early trading today, up by over......(read more)
AEterna Zentaris Inc. (USA) (NASDAQ:AEZS)

AEterna Zentaris Inc. (USA) (AEZS), Tower Group International, Ltd. (TWGP): Stocks to Get on Your Watchlist

I follow quite a lot of companies, so the usefulness of a watchlist to me cannot be overstated. Without my watchlist, I’d be unable to keep up on......(read more)
AEterna Zentaris Inc. (USA) (NASDAQ:AEZS)

ImmunoGen, Inc. (IMGN), AEterna Zentaris Inc. (USA) (AEZS) – Tackling Cancer: Your Best Investing Ideas

Over the past three months, we’ve taken a deep dive into the 12 cancer types most likely to be diagnosed in the U.S. this year according to the......(read more)
AstraZeneca plc (ADR) (NYSE:AZN)

AstraZeneca plc (ADR) (AZN): Where Investment Dollars Are Headed

As I noted 10 weeks ago, cancer statistics are both staggering and disappointing. Although cancer deaths per 100,000 people have been on the downswing......(read more)

This Week in Biotech: Navidea Biopharmaceuticals Inc (NAVB), Sinovac Biotech Ltd. (SVA) and More

With the SPDR S&P Biotech (ETF) (NYSEARCA:XBI) up 28% over the trailing-12-month period, it’s evident that investment dollars are willingly......(read more)
Peregrine Pharmaceuticals (NASDAQ:PPHM)

Peregrine Pharmaceuticals (PPHM)’s Epic Failure (Maybe)

Clinical trial 101 says if a trial passes all of its primary endpoints it’s successful. If it doesn’t, it’s not. With some exceptions......(read more)